- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 1, 2025 | 21.38M sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $60.21M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $37.23M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $45.95M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $57.54M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $229.46M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $247.84M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $242.86M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $299.85M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $322.99M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $376.65M |
| Net Income | Q2 2025 · Sep 30, 2024 | −$116.05M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$31.16M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$64.56M |
| Net Income | Q2 2025 · Dec 31, 2023 | −$33.41M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 21.17M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 21.13M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $2.46M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$53.59M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $166.11M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $191.88M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $216.74M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$1.47 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$3.06 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$1.47 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$3.06 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $14.24M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $30.75M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $35.59M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $71.96M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$32.77M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$67.65M |
| Revenue | Q2 2025 · Mar 31, 2024 | $17.05M |
| Revenue | Q2 2025 · Mar 31, 2024 | $35.06M |